BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piano S, Gambino C, Vettore E, Calvino V, Tonon M, Boccagni P, Gringeri E, Germani G, Burra P, Cillo U, Angeli P. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome. Hepatology 2021;73:1909-19. [PMID: 32870499 DOI: 10.1002/hep.31529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kulkarni AV, Rabiee A, Mohanty A. Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Piano S, Angeli P. REPLY. Hepatology 2021. [PMID: 34097748 DOI: 10.1002/hep.31989] [Reference Citation Analysis]
3 Kulkarni AV, Kumar P, Sharma M, Menon B, Reddy DN, Rao PN. Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better? Hepatology 2021;73:2619-20. [PMID: 33230855 DOI: 10.1002/hep.31657] [Reference Citation Analysis]
4 Li F, Wang T, Zhan L, Jia Z, Luo T, Chen S, Zhao Q, Guo Z, He X, Wang D. Clinical Outcomes of Liver Transplantation in Patients With Hepatorenal Syndrome: A Single Center Study in China. Front Surg 2022;8:781648. [DOI: 10.3389/fsurg.2021.781648] [Reference Citation Analysis]
5 Khemichian S, Francoz C, Nadim MK. Advances in management of hepatorenal syndrome. Curr Opin Nephrol Hypertens 2021;30:501-6. [PMID: 34397647 DOI: 10.1097/MNH.0000000000000730] [Reference Citation Analysis]
6 Simbrunner B, Trauner M, Reiberger T, Mandorfer M. Recent advances in the understanding and management of hepatorenal syndrome. Fac Rev 2021;10:48. [PMID: 34131658 DOI: 10.12703/r/10-48] [Reference Citation Analysis]
7 Dong V, Nadim MK, Karvellas CJ. Post-Liver Transplant Acute Kidney Injury. Liver Transpl 2021. [PMID: 33963666 DOI: 10.1002/lt.26094] [Reference Citation Analysis]
8 Yu YT, Liu J, Hu B, Wang RL, Yang XH, Shang XL, Wang G, Wang CS, Li BL, Gong Y, Zhang S, Li X, Wang L, Shao M, Meng M, Zhu F, Shang Y, Xu QH, Wu ZX, Chen DC. Expert consensus on the use of human serum albumin in critically ill patients. Chin Med J (Engl) 2021;134:1639-54. [PMID: 34397592 DOI: 10.1097/CM9.0000000000001661] [Reference Citation Analysis]
9 Pacheco MP, Carneiro-D'Albuquerque LA, Mazo DF. Current aspects of renal dysfunction after liver transplantation. World J Hepatol 2022; 14(1): 45-61 [DOI: 10.4254/wjh.v14.i1.45] [Reference Citation Analysis]
10 Jindal A, Jagdish RK. Letter to the Editor: Response to Terlipressin Plus Albumin in Hepatorenal Syndrome-Need a Closer Look! Hepatology 2021. [PMID: 34091933 DOI: 10.1002/hep.31990] [Reference Citation Analysis]
11 Mauro E, Garcia-Olveira L, Gadano A. End-stage liver disease: Management of hepatorenal syndrome. Liver Int 2021;41 Suppl 1:119-27. [PMID: 34155791 DOI: 10.1111/liv.14866] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Solé C, Ma AT, Solà E, Carol M, Fabrellas N, Juanola A, Napoleone L, Gratacós-Ginès J, Bassegoda O, Cervera M, Pérez M, Rubio AB, Avitabile E, Morales-Ruiz M, Graupera I, Pose E, Kamath PS, Ginès P. Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome. Liver Int 2021;41:2729-32. [PMID: 34569697 DOI: 10.1111/liv.15069] [Reference Citation Analysis]
13 Liu S, Meng Q, Xu Y, Zhou J. Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion. Gastroenterol Rep (Oxf) 2021;9:505-20. [PMID: 34925848 DOI: 10.1093/gastro/goab040] [Reference Citation Analysis]